EDWARDS LIFESCIENCES ANNOUNCES $500 MILLION ACCELERATED SHARE REPURCHASE

Posted on

IRVINE, Calif.–(BUSINESS WIRE)– Edwards Lifesciences (NYSE: EW) today announced that it has executed an accelerated share repurchase agreement (“ASR”) to repurchase $500 million of Edwards’ common stock. With this transaction, Edwards has repurchased more than $800 million of shares in 2025. Under the terms of this ASR, Edwards will receive an initial delivery of approximately […]

Read More

Nusano Cuts Ribbon on State-of-the-Art Radioisotope Production Facility

Posted on

WEST VALLEY CITY, Utah – Aug. 21, 2025 – Nusano, a physics company transforming the production of radioisotopes, today cut the ribbon on its 190,000-square-foot radioisotope production facility. The site will be capable of producing more than 40 different radioisotopes for use in cancer diagnostics and therapeutics, as well as industrial applications, such as long-lived […]

Read More

Sethera Therapeutics Unveils Breakthrough Enzymatic Platform for Next-Generation Peptide Drugs

Posted on

SALT LAKE CITY, Utah August 21, 2025 — Sethera Therapeutics today announced publication in the Proceedings of the National Academy of Sciences (PNAS) of peer-reviewed results describing an enzymatic crosslinking platform that forges durable thioether “staples,” locking peptides into drug-like cyclic architectures. The platform works across a broad range of substrates, including sequences built entirely […]

Read More